Responses
ePoster
EP635 Minimizing the dose of oral megestrol in combination with the levonorgestrel-releasing intrauterine device: an equally effective approach for the conservative management of atypical hyperplasia and well differentiated endometrial carcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.